M&A Deal Summary

Smith & Nephew Acquires Plus Orthopedics Holding AG

On March 12, 2007, Smith & Nephew plc acquired medical products company Plus Orthopedics Holding AG from Invision AG for 889M USD

Acquisition Highlights
  • This is Smith & Nephew’s 7th transaction in the Medical Products sector.
  • This is Smith & Nephew’s 2nd largest (disclosed) transaction.
  • This is Smith & Nephew’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2007-03-12
Target Plus Orthopedics Holding AG
Sector Medical Products
Buyer(s) Smith & Nephew plc
Sellers(s) Invision AG
Deal Type Add-on Acquisition
Deal Value 889M USD

Target

Plus Orthopedics Holding AG

Rotkreuz, Switzerland
PlusOrthopedics Holding AG. is a orthopedic company with over 850 employees providing implants and technically advanced surgical solutions. Plus has focused its activities on the development of implants for hips, knees, shoulders and small joints.

Search 169,781 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Smith & Nephew plc

Watford, United Kingdom

website


Category Company
Founded 1856
SectorMedical Products
Employees18,000
Revenue 4.6B USD (2020)
DESCRIPTION

Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, the United Kingdom.


DEAL STATS #
Overall 8 of 33
Sector (Medical Products) 7 of 22
Type (Add-on Acquisition) 7 of 25
Country (Switzerland) 1 of 2
Year (2007) 1 of 2
Size (of disclosed) 2 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-07-11 OsteoBiologics, Inc.

Wermelskirchen, Germany

OsteoBiologics, Inc. located in San Antonio, Texas, develops and manufactures bioabsorbable polymeric scaffolds, films, and related instrumentation for the repair and replacement of bone and articular cartilage. In July 2006, the Company was sold to Smith & Nephew plc for $72.3 million.

Buy $72M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-01 BlueSky Medical Group, Inc.

Carlsbad, California, United States

BlueSky, which manufactures the Versatile 1 wound vacuum system, has an estimated 5% of the global market for pumps and accessories used in negative-pressure therapy.

Buy $110M

Seller(S) 1

SELLER

Invision AG

Zug, Switzerland

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1996
PE ASSETS 400M EUR
SizeMiddle-Market
Type Sector Agnostic
DESCRIPTION

Invision AG is a private equity firm focused on growth capital investments in European companies or companies with opportunities in Europe. Target sectors include information technology, software, electronics, telecommunications, medical devices, healthcare services, financial services, and media. Invision looks to invest between €20 and €100 million in businesses generating €25 and €200 million in sales. Invision was formed in 1996 as the corporate venture capital arm of Metro Holding. Invision is based in Zug, Switzerland.


DEAL STATS #
Overall 8 of 24
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 2 of 8
Country (Switzerland) 2 of 7
Year (2007) 2 of 6
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Cosmo Pharmaceuticals S.p.A.

Lainate, Italy

Cosmo is an emerging fully-integrated speciality pharmaceutical company that aims to become a global leader in the market of optimised therapies for selected gastro-intestinal diseases. The company's proprietary clinical development pipeline specifically addresses innovative treatments for Inflammatory Bowel Diseases (IBD), such as Ulcerative Colitis and Crohn's Disease, as well as for colon infections.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-03-27 Thommen Medical AG

Waldenburg, Switzerland

Thommen Medical develops, manufactures and distributes a dental implant system under the brand name SPI, Swiss Precision Implant.

Sell -